Shares in GlaxoSmithKline have reacted favourably to the drug developer's 2010 figures. Generic competition hit revenues, which were down 1% to £28.4bn. Pre-tax profits were down to £4.5bn from £8.7bn. The full-year dividend was raised by 7% to 65p a share. Drive technology developer Torotrak is falling back following yesterday's trading statement and organisational restructuring. Trading is as planned and there was a £1m cash inflow from a new deal last month. Torotrak is targeting a reduction of between £1.6m and £1.9m in annual costs. The costs of the reorganisation will be £600,000. The board is taking pay cuts as part of the cost savings. FTSE TechMARK - Risers Sepura (SEPU) 50.00p +4.17%Asterand (ATD) 20.25p +3.85%BATM Advanced Communications Ltd. (BVC) 27.00p +3.85%Promethean World (PRW) 58.25p +3.56%BT Group (BT.A) 183.90p +3.03%GlaxoSmithKline (GSK) 1,151.50p +2.13%Antisoma (ASM) 2.27p +1.79%ARM Holdings (ARM) 579.50p +1.40%E2V Technologies (E2V) 117.00p +1.30%Puricore (PURI) 53.50p +0.94%FTSE TechMARK - Fallers AEA Technology Group (AAT) 4.75p -5.00%Torotrak (TRK) 21.25p -4.49%Computacenter (CCC) 446.40p -2.43%Sage Group (SGE) 293.70p -2.33%Ricardo (RCDO) 342.00p -2.29%Renovo Group (RNVO) 71.50p -2.05%Filtronic (FTC) 36.50p -2.01%RM (RM.) 165.00p -1.79%Anite (AIE) 64.00p -1.54%Vernalis (VER) 48.00p -1.54%